Publications Office of the EU
Supply of exclusive medicines: Darbepoetin alfa (ARANESP), Evolocumab (REPATHA), Etelcalcetide (PARSABIV) and Filgrastim (NEUPOGEN vial). - EU tenders
DisplayCustomHeader
Procurement Detail Actions Portlet
OP Portal - Procurement - Details

This page contains content generated automatically to improve findability and accessibility

- indicates text translated automatically in your browsing language

Supply of exclusive medicines: Darbepoetin alfa (ARANESP), Evolocumab (REPATHA), Etelcalcetide (PARSABIV) and Filgrastim (NEUPOGEN vial). Text automatically translated in your browsing language Automatically translated

  • Awarded
    04/11/2024
  • Today
    08/12/2024
Status
Awarded
Type of contract
Supplies
Subject for Renewal
No
Buyer
Servicio Madrileno de Salud, Hospital Universitario La Paz
Place of performance
NUTS code: Multiple place of performance
Location of buyer
NUTS code: ES300 Madrid
Business sector (Main CPV)
33600000 Pharmaceutical products
Total estimated contract value (excluding VAT)
Not available
Total final contract value (excluding VAT)
494,598.60 EUR
Tender reference number
Not available
Description

Supply of exclusive medicines: Darbepoetin alfa (ARANESP), Evolocumab (REPATHA), Etelcalcetide (PARSABIV) and Filgrastim (NEUPOGEN vial). Text automatically translated in your browsing language Automatically translated

Submission Method
Not available
Tenders may be submitted
Not available
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
Not available
Place of performance
Award method
Criterion:
Type: cost
Description: Coste
Weight (percentage, exact): 100
Estimated value
Not available
Final contracted value
494,598.60 EUR
Award of contract
Official name: AMGEN S.A.
Postal address:
Town: BARCELONA
Postal code: 08039
Country:
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.